摘要:
In the context of IEEE 802.11 WLAN networks, enhancement to the Relaxed Deterministic Backoff (R-DEB) for random access of shared (Medium Access Control MAC) method. For all available candidate resource slots, a busy index is calculated that reflects the level of use/occupation in the past and infers a probability of use in the future by another concurring device. The method assumes the use of a sub-set of resource slots for transmission, and updates this set by replacing resource slots for which collisions are frequent with a not currently used candidate resource for which the busy index is the lowest. Passive Spoofing/overhearing of all resources for clear channel assessment (CCS) is used for resource monitoring purposes.
摘要:
A system and method for determining an initial mean open loop power level of a pilot channel of a reverse traffic channel for a mobile terminal. The initial open loop power level enables handoff of an active call from a first access network to a second access network. A handoff initialization request is from the first access network. A mean received power level of the forward link of the second access network is measured and transmitted to the second access network. An open loop power adjustment factor is received from the second access network. The initial mean open loop power level is set based on the open loop power adjustment factor.
摘要:
A method and a device for preparing a media stream containing more than one component stream for picture-in-picture applications are described along with the corresponding method and device for rendering the media stream in a picture-in-picture mode. The invention allows for live and dynamic picture-in-picture rendering of the component streams contained in the media stream. Extensions to the media formats that shall support various multimedia applications, such as the MPEG-2 Transport Stream and ISO media format, are proposed to enable such a dynamic picture-in-picture functionality.
摘要:
A method for industrially preparing a nitrogen substituted 6-amino-5,6,7,8-tetrahydronaphthol is disclosed. The method comprises includes reacting a nitrogen substituted amino-5,6,7,8-tetrahydronaphthol compound of formula (II) with a 2-substituted ethyl sulfonate compound of formula (III) under an alkaline condition and in the presence of a sulfite.
摘要:
A method and apparatus for improving power performance of a wireless adapter which adopts a time slicing scheme by dividing a beacon interval into multiple slices, and assigning these slices to the stations through the beacon frame. The stations wakeup at the appointed slices to receive their buffered frames from an access point, and may enter into sleep state once the transactions conclude. A further embodiment including formatting data into a control frame for use in a wireless local area network, the frame including an indication, for each station associated with the wireless local area network, whether frames are buffered awaiting transmission to each respective station, a number of time intervals between control frames, and at which time interval the transmission of the buffered frames will begin for each station having buffered frames awaiting transmission.
摘要:
The disclosure provides a composition comprising rotigotine or a pharmaceutically acceptable salt thereof; at least one poly(lactide-co-glycolide) (PLGA); and at least one fatty acid, wherein the at least one fatty acid is at least 0.5% in weight relative to the total weight of the composition. The composition as disclosed herein has significantly reduced burse release effect. The disclosure also provides a method of treating Parkinson's disease comprising administering an effective amount of the composition as disclosed to a subject in need thereof.
摘要:
Embodiments of the present disclosure provide an authentication method and an electronic device. The method includes: generating by a first device an authentication request if a predetermined condition exists between the first device and a second device, when the first device is in a locking state, wherein the first device has the locking state and a non-locking state; receiving by the first device authentication information, the authentication information being input in response to the authentication request; and authenticating the second device using the authentication information. Through the present disclosure, others cannot directly damage or copy data in the first device in a connection manner such as using a data line even if they get hold of the device, as long as the first device is in the locking state. Thus, the security of the data in the first device is ensured. Since a complex synchronization authentication protocol does not need to be developed by synchronization software and the first device, and the present disclosure is compatible with various commercially available synchronization software, the implementation method is simple and efficient, and the compatibility is good.
摘要:
Systems, methods, and apparatuses are directed to reconfiguring a time division duplex (TDD) uplink/downlink (UL/DL) configuration. A first TDD UL/DL configuration can be identified for a first radio frame. A second TDD UL/DL configuration can be identified for a second radio frame adjacent the first radio frame. The second TDD UL/DL configuration can be identified based, at least in part, on one or more subframes of the second TDD UL/DL configuration that can communicate hybrid automatic repeat request (HARQ) acknowledgement/negative acknowledgement (ACK/NACK) indicators for corresponding subframes of the first TDD UL/DL configuration.
摘要翻译:系统,方法和装置旨在重新配置时分双工(TDD)上行链路/下行链路(UL / DL)配置。 可以为第一无线电帧识别第一TDD UL / DL配置。 可以为与第一无线电帧相邻的第二无线电帧识别第二TDD UL / DL配置。 可以至少部分地基于可以传送混合自动重传请求(HARQ)确认/否定确认(ACK / NACK)指示符的第二TDD UL / DL配置的一个或多个子帧来识别第二TDD UL / DL配置 对于第一TDD UL / DL配置的相应子帧。
摘要:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R3, R3a, and R3b are defined herein.